Pool Testing as a Strategy for Prevention of SARS-CoV-2 Outbreaks in Schools: Protocol for a Feasibility Study.

COVID-19 PCR SARS-CoV-2 gargle test monitoring pool testing schools surveillance test strategy

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
28 May 2021
Historique:
received: 10 03 2021
accepted: 07 04 2021
revised: 01 04 2021
pubmed: 13 5 2021
medline: 13 5 2021
entrez: 12 5 2021
Statut: epublish

Résumé

School closures are a widely implemented strategy for limiting infection spread in the current COVID-19 pandemic. The negative impact of school closures on children and young people is increasingly apparent, however. We aim to evaluate the feasibility of an infection monitoring program in schools to enable targeted quarantining to replace school closures. The program is currently being implemented in two model schools in Magdeburg, Germany, within the framework of the Study of Coronavirus Outbreak Prevention in Magdeburg Schools (Studie zur Ausbruchsvermeidung von Corona an Magdeburger Schulen [STACAMA]). Five pupils per class are pseudorandomly selected twice a week and asked to provide a gargle sample over a 16-week evaluation period. RNA is extracted from each sample individually in a laboratory and pooled according to school class for real-time reverse transcription polymerase chain reaction (rRT-PCR) analysis. Immediate individual sample testing will be carried out in the case of a positive pool test. Individual RNA extraction prior to pooling and application of rRT-PCR result in high test sensitivity. Testing will be performed in strict adherence to data protection standards. All participating pupils will receive a 16-digit study code, which they will be able to use to access their test. When the study commenced on December 2, 2020, 520 (52%) pupils and their families or guardians had consented to study participation. The study was suspended after four test rounds due to renewed school closures resulting from rising regional infection incidence. Testing resumed when schools reopened on March 8, 2021, at which time consent to participation was provided for 54% of pupils. We will quantitatively and qualitatively evaluate the logistics and acceptability of the program. The findings from this study should inform the design of infection surveillance programs in schools based on gargle samples and a PCR-based pool testing procedure, enabling the identification of aspects that may require adaptation before large-scale implementation. Our focus on each step of the logistics and on the experiences of families should enable a robust assessment of the feasibility of such an approach. DERR1-10.2196/28673.

Sections du résumé

BACKGROUND BACKGROUND
School closures are a widely implemented strategy for limiting infection spread in the current COVID-19 pandemic. The negative impact of school closures on children and young people is increasingly apparent, however.
OBJECTIVE OBJECTIVE
We aim to evaluate the feasibility of an infection monitoring program in schools to enable targeted quarantining to replace school closures. The program is currently being implemented in two model schools in Magdeburg, Germany, within the framework of the Study of Coronavirus Outbreak Prevention in Magdeburg Schools (Studie zur Ausbruchsvermeidung von Corona an Magdeburger Schulen [STACAMA]).
METHODS METHODS
Five pupils per class are pseudorandomly selected twice a week and asked to provide a gargle sample over a 16-week evaluation period. RNA is extracted from each sample individually in a laboratory and pooled according to school class for real-time reverse transcription polymerase chain reaction (rRT-PCR) analysis. Immediate individual sample testing will be carried out in the case of a positive pool test. Individual RNA extraction prior to pooling and application of rRT-PCR result in high test sensitivity. Testing will be performed in strict adherence to data protection standards. All participating pupils will receive a 16-digit study code, which they will be able to use to access their test.
RESULTS RESULTS
When the study commenced on December 2, 2020, 520 (52%) pupils and their families or guardians had consented to study participation. The study was suspended after four test rounds due to renewed school closures resulting from rising regional infection incidence. Testing resumed when schools reopened on March 8, 2021, at which time consent to participation was provided for 54% of pupils. We will quantitatively and qualitatively evaluate the logistics and acceptability of the program.
CONCLUSIONS CONCLUSIONS
The findings from this study should inform the design of infection surveillance programs in schools based on gargle samples and a PCR-based pool testing procedure, enabling the identification of aspects that may require adaptation before large-scale implementation. Our focus on each step of the logistics and on the experiences of families should enable a robust assessment of the feasibility of such an approach.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
DERR1-10.2196/28673.

Identifiants

pubmed: 33979297
pii: v10i5e28673
doi: 10.2196/28673
pmc: PMC8166266
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e28673

Informations de copyright

©Catherine M Sweeney-Reed, Doreen Wolff, Jakob Niggel, Michael Kabesch, Christian Apfelbacher. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 28.05.2021.

Références

JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Lancet Child Adolesc Health. 2020 May;4(5):397-404
pubmed: 32272089
Euro Surveill. 2020 May;25(21):
pubmed: 32489179
PLoS One. 2020 Sep 22;15(9):e0239492
pubmed: 32960929
BMJ Paediatr Open. 2020 Jun 21;4(1):e000722
pubmed: 32596514
Arch Dis Child. 2020 Jul;105(7):618-619
pubmed: 32371442
Psychiatry Res. 2021 Jan;295:113560
pubmed: 33187723
Int J Psychol. 2020 Nov 24;:
pubmed: 33236341
J Clin Microbiol. 2020 Oct 21;58(11):
pubmed: 32883744
BMJ Paediatr Open. 2020 May 4;4(1):e000701
pubmed: 32420459
J Paediatr Child Health. 2020 Jul;56(7):1013-1017
pubmed: 32619327
Clin Infect Dis. 2020 Oct 19;:
pubmed: 33075138
Health Promot Perspect. 2020 Nov 07;10(4):293-294
pubmed: 33312923
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Euro Surveill. 2020 Sep;25(38):
pubmed: 32975186
Infect Control Hosp Epidemiol. 2021 Feb;42(2):248-249
pubmed: 32389132
Lancet. 2020 May 2;395(10234):1420-1421
pubmed: 32325027
Acta Paediatr. 2020 Jun;109(6):1088-1095
pubmed: 32202343
Paediatr Child Health (Oxford). 2020 Dec;30(12):430-437
pubmed: 32959000
Math Biosci. 2017 May;287:93-104
pubmed: 27671169
Lancet Digit Health. 2020 Apr;2(4):e201-e208
pubmed: 32309796
Euro Surveill. 2020 Sep;25(36):
pubmed: 32914746
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
Lancet Public Health. 2020 May;5(5):e271-e278
pubmed: 32251626
JAMA Pediatr. 2021 Feb 1;175(2):143-156
pubmed: 32975552
Am J Clin Pathol. 2020 May 5;153(6):715-718
pubmed: 32304208
J Public Econ. 2020 Oct;190:104258
pubmed: 32863462
Lancet Public Health. 2020 May;5(5):e243-e244
pubmed: 32275858
Arch Dis Child. 2021 Feb;106(2):111-113
pubmed: 32747375
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
Clin Infect Dis. 2020 Nov 19;71(16):2073-2078
pubmed: 32358960
BMJ. 2020 Mar 22;368:m1163
pubmed: 32201376
BMJ Open. 2020 Sep 29;10(9):e042867
pubmed: 32994262
Obesity (Silver Spring). 2020 Jun;28(6):1008-1009
pubmed: 32227671
Front Pediatr. 2021 Mar 16;9:645577
pubmed: 33796490
GMS Hyg Infect Control. 2020 May 28;15:Doc11
pubmed: 32547911
J Clin Virol. 2015 Mar;64:59-63
pubmed: 25728080
Sci Adv. 2021 Jan 1;7(1):
pubmed: 33219112
J Clin Microbiol. 2021 Mar 19;59(4):
pubmed: 33514627

Auteurs

Catherine M Sweeney-Reed (CM)

Neurocybernetics and Rehabilitation, Department of Neurology, Otto von Guericke University Magdeburg, Magdeburg, Germany.
Center for Behavioral Brain Sciences, Otto von Guericke University Magdeburg, Magdeburg, Germany.

Doreen Wolff (D)

Institute of Social Medicine and Health Systems Research, Otto von Guericke University Magdeburg, Magdeburg, Germany.

Jakob Niggel (J)

University of Regensburg, Regensburg, Germany.
MaganaMed GbmH, Regensburg, Germany.

Michael Kabesch (M)

University Children's Hospital Regensburg (KUNO), Hospital St. Hedwig of the Order of St. John, Regensburg, Germany.
Research and Development Campus Regensburg (WECARE), Hospital St. Hedwig of the Order of St. John and University of Regensburg, Regensburg, Germany.

Christian Apfelbacher (C)

Institute of Social Medicine and Health Systems Research, Otto von Guericke University Magdeburg, Magdeburg, Germany.
Research and Development Campus Regensburg (WECARE), Hospital St. Hedwig of the Order of St. John and University of Regensburg, Regensburg, Germany.

Classifications MeSH